Definitive Contract 75A50123C00071

Award Date 9/29/23
Potential Completion Date 3/27/29
Potential Value $17M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $15,958,895.53 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is to advance the development of the Biofire Emerging COV Panel, a nucleic acid amplification test panel for use on the Biofire FilmArray 2.0 and FilmArray Torch molecular diagnostic platforms. This contract aligns with ASPR's mission to support the...
This $5,410,602.21 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Biofire Defense LLC, a manufacturer of biological agent identification products and diagnostic solutions. The contract has an ultimate completion date of December 18, 2026 and does not utilize a set-aside designation. The contract requires Biofire Defense to provide all necessary services, personnel, material, equipment, and facilities to add the Biofire...
This is a firm fixed price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract has a ceiling value of $17,254.06 and an ultimate completion date of April 22, 2024. The contract provides medical supplies, with no set-aside designation. Biofire Defense has received prior federal contracts and grants, including a $6.2 million...
This is a $472,500.00 firm fixed-price purchase order awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract provides an extended warranty for the company's TORCH MODULE product, with a period of performance through September 29, 2027. There is no set-aside designation for this award. Biofire Defense has previously received other federal contract and grant awards from the...
This $30,788.88 firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer within the Department of Health and Human Services to Biofire Defense LLC, a manufacturer of biological agent identification products including the Biofire FilmArray and RAZOR Mk II systems. The contract supports biodefense and infectious disease diagnostics, with no set-aside designation. Biofire Defense has previously supported the Department of Defense, Department of State, National...
This is a firm fixed-price purchase order awarded by the Bureau of Medical Services, an agency of the U.S. government, to Biofire Defense LLC for an extended product warranty for the Biofire FilmArray equipment. The contract has a ceiling value of $253,152.00 and a period of performance through January 20, 2027. Biofire Defense LLC is a for-profit limited liability company that manufactures biological agent identification products, including the FilmArray system, and has received previous...
This is a $9,332,740.00 firm fixed price federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Biofire Defense LLC for the advanced development of multiplex diagnostic platforms for infectious diseases. The contract has an ultimate completion date of April 12, 2022 and does not have a set-aside designation. Biofire Defense LLC is a for-profit limited liability company that provides...
This is a $188,621 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Biofire Defense LLC, a for-profit limited liability company that provides biological agent identification products and services. The contract is for "closely associated functions" and does not have a set-aside designation. Through this award, Biofire Defense will likely provide a range of goods and services related to biological threat...
This is a firm fixed-price purchase order awarded by the Defense Advanced Research Projects Agency (DARPA) to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract, valued at $85,985.35, is for the delivery of WRAIR_BIOFIRE FILM ARRAY goods and services. Biofire Defense has previously received prime and subcontract awards from various federal agencies for biological threat detection, infectious disease testing, and...
This is a $227,968 firm fixed price purchase order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of Global Fever Panel Kits, with a completion date of October 30, 2020. The contract has no set-aside designation. Biofire Defense has previously received other federal contracts and grants related to biological...

This is a $17,325,268.78 cost-plus-fixed-fee contract awarded to Biofire Defense LLC on September 29, 2023 by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract objective is to advance the development of Biofire's Emerging Flu Panel as a nucleic acid detection assay for use on the Biofire FilmArray Torch and Spotfire platforms. This work is related to a previous Broad Agency Announcement from the Biomedical Advanced Research and Development Authority (BARDA) seeking proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic threats. The contract has an ultimate completion date of March 27, 2029 and does not utilize any set-aside designations.

Generated 11/22/24, 9:47 AM